Staff Profile

Qualifications

FMedSci

FRCP

MD

MA

MB BS

Roles and Responsibilities

Pro-Vice Chancellor, Faculty of Medical Sciences, Newcastle University

Director, Newcastle Health Innovation Partners NIHR/NHS-E designated Academic Health Science Centre

Honorary Consultant Neurologist, Newcastle upon Tyne Hospitals NHS Foundation Trust

Trustee, Daft as a Brush Cancer Charity

Council member and Trustee, Academy of Medical Sciences

Biopic

Professor David Burn took up the position of Pro-Vice-Chancellor of the Faculty of Medical Sciences on the 1st February 2017. The Faculty delivers impact through excellence in and close integration of research, teaching and engagement across three research institutes and five schools. 

Professor Burn is also Professor of Movement Disorders Neurology and Honorary Consultant Neurologist for Newcastle upon Tyne Hospitals NHS Foundation Trust. His first degree was at Oxford (Physiological Sciences), returning to his native North East for clinical training and early medical jobs, including neurology. After further neurology training and undertaking research in London (National Hospital for Neurology and Neurosurgery, Queen Square and Hammersmith Hospital) he was appointed as a Consultant Neurologist and Senior Lecturer in Newcastle in 1994.   

Professor Burn has an international reputation for research in dementia associated with Parkinson’s. He is an Emeritus NIHR Senior Investigator and chaired the NIHR Translational Research Collaboration for Dementia (2017-2023). He was chair of the Northern Health Science Alliance Board 2017-2024 and was President of the Association of British Neurologists between 2019-2021.   

He is President Elect of the International Parkinson and Movement Disorder Society (2023-25) and was elected to Council of the Academy of Medical Sciences in 2023.

Research Interests

My research aims to improve the diagnosis and management of Parkinson’s disease, the Lewy body dementias and Progressive Supranuclear Palsy (PSP).  I played a key role in an International Task Force to develop the first set of Diagnostic Criteria for Dementia associated with Parkinson's disease and the International Consortium to define new diagnostic criteria for Dementia with Lewy Bodies.  My group is identifying predictors of dementia in Parkinson's disease, supported by a programme grant from Parkinson's UK to identify people with Parkinson's disease at high risk of incident dementia (ICICLE-PD). Recent outputs from this work have highlighted the high burden of non-motor symptoms, and a putative cholinergic basis underpinning impaired gait speed and attention, in early Parkinson’s.  More recently, my work has involved the study of apomorphine as a putative anti-amyloid agent (using clinicopathological methods) and ghrelin as a biomarker for cognitive impairment in Parkinson's.

I have contributed towards the development of new treatments for patients with movement disorders including a multi-centre randomised controlled trial of rivastigmine in the treatment of dementia in Parkinson's.  The results from this trial were incorporated into 2006 NICE-PD guidelines. I lead a multicentre NIHR HTA-funded study to establish the clinical and cost effectiveness of donepezil in early dementia associated with Parkinson's disease (MUSTARDD-PD).  My work in dementia with Lewy bodies has shown that physicians may prescribe levodopa safely to people with this disorder, although motor response may be sub-optimal.

I have made a significant impact in our understanding of the neurodegenerative disease PSP (average life-span 6-7 years). My work has highlighted the prevalence of PSP in the UK, its protean clinical features at presentation and the natural history.  The PSP (Europe) Association used outcomes from this work to raise public and professional awareness of the disorder, to lobby parliament, and establish a UK-wide “best clinical care” model for people.

• Articles

  • Burn DJ. Why it is Important to Publish. Movement Disorders Clinical Practice 2024, (ePub ahead of Print).
  • Kalia LV, Berg D, Kordower JH, Shannon KM, Taylor J-P, Cardoso F, Goldman JG, Jeon B, Meissner WG, Tijssen MAJ, Burn DJ, Fung VSC. Movement Disorders Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions. Movement Disorders 2024, ePub ahead of Print.
  • Tan MMX, Lawton MA, Pollard MI, Brown E, Real R, Carrasco AM, Bekadar S, Jabbari E, Reynolds RH, Iwaki H, Blauwendraat C, Kanavou S, Hubbard L, Malek N, Grosset KA, Bajaj N, Barker RA, Burn DJ, Bresner C, Foltynie T, Wood NW, Williams-Gray CH, Andreassen OA, Toft M, Elbaz A, Artaud F, Brice A, Corvol J-C, Aasly J, Farrer MJ, Nalls MA, Singleton AB, Williams NM, Ben-Shlomo Y, Hardy J, Hu MTM, Grosset DG, Shoai M, Pihlstrom L, Morris HR. Genome-wide determinants of mortality and motor progression in Parkinson’s disease. npj Parkinson's Disease 2024, 10(1), 113.
  • Gerakios F, Yarnall AJ, Bate G, Wright L, Davis D, Stephan BCM, Robinson L, Brayne C, Stebbins G, Taylor JP, Burn DJ, Allan L, Richardson SJ, Lawson RA. Delirium is more common and associated with worse outcomes in Parkinson's disease compared to older adult controls: results of two prospective longitudinal cohort studies. Age and Ageing 2024, 53(3), afae046.
  • Cardoso F, Goetz CG, Mestre TA, Sampaio C, Adler CH, Berg D, Bloem BR, Burn DJ, Fitts MS, Gasser T, Klein C, de Tijssen MAJ, Lang AE, Lim S-Y, Litvan I, Meissner WG, Mollenhauer B, Okubadejo N, Okun MS, Postuma RB, Svenningsson P, Tan LCS, Tsunemi T, Wahlstrom-Helgren S, Gershanik OS, Fung VSC, Trenkwalder C. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease. Movement Disorders 2024, 39(2), 259-266.
  • Wright LM, Donaghy PC, Burn DJ, Taylor JP, O'Brien JT, Yarnall AJ, Matthews FE, Firbank MJ, Thomas AJ, Lawson RA. Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: A longitudinal study. Parkinsonism and Related Disorders 2023, 113, 105762.
  • Cullinan RJ, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM, Lawson RA. Documentation and Diagnosis of Delirium in Parkinson’s Disease. Acta Psychiatrica Scandinavica 2023, 147(5), 527-535.
  • Xing Y, Sapuan AH, Martin-Bastida A, Naidu S, Tench C, Evans J, Sare G, Schwarz ST, Al-bachari S, Parkes LM, Kanavou S, Raw J, Silverdale M, Bajaj N, Pavese N, Burn D, Piccini P, Grosset DG, Auer DP. Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. Movement Disorders 2022, 37(5), 1028-1039.
  • Chelban V, Nikram E, Perez-Soriano A, Wilke C, Foubert-Samier A, Vijiaratnam N, Guo T, Jabbari E, Olufodun S, Gonzalez M, Senkevich K, Laurens B, Peran P, Rascol O, Le Traon AP, Todd EG, Costantini AA, Alikhwan S, Tariq A, Ng BL, Munoz E, Painous C, Compta Y, Junque C, Segura B, Zhelcheska K, Wellington H, Schols L, Jaunmuktane Z, Kobylecki C, Church A, Hu MTM, Rowe JB, Leigh PN, Massey L, Burn DJ, Pavese N, Foltynie T, Pchelina S, Wood N, Heslegrave AJ, Zetterberg H, Bocchetta M, Rohrer JD, Marti MJ, Synofzik M, Morris HR, Meissner WG, Houlden H. Neurofilament light levels predict clinical progression and death in multiple system atrophy. Brain 2022, 145(12), 4398-4408.
  • Lawton M, Tan MMX, Ben-Shlomo Y, Baig F, Barber T, Klein JC, Evetts SG, Millin S, Malek N, Grosset K, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood N, Grosset DG, Hu MT-M. Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts. Journal of Neurology, Neurosurgery and Psychiatry 2022, 93(9), 952-959.
  • Sigurdsson HP, Yarnall AJ, Galna B, Lord S, Alcock L, Lawson RA, Colloby SJ, Firbank MJ, Taylor JP, Pavese N, Brooks DJ, O'Brien JT, Burn DJ, Rochester L. Gait-related metabolic covariance networks at rest in Parkinson’s disease. Movement Disorders 2022, 37(6), 1222-1234.
  • Ray NH, Lawson RA, Martin SL, Sigurdsson HP, Wilson J, Galna B, Lord S, Alcock L, Duncan GW, Khoo TK, O'Brien JT, Burn DJ, Taylor JP, Rea R, Bergamino M, Rochester L, Yarnall AJ. Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson’s disease. Brain 2022, 146(3), 1053–1064.
  • Mc Ardle R, Del Din S, Morris R, Alcock L, Yarnall AJ, Burn DJ, Rochester L, Lawson RA. Factors Influencing Habitual Physical Activity in Parkinson’s Disease: Considering the Psychosocial State and Wellbeing of People with Parkinson’s and Their Carers. Sensors 2022, 22(3), 871.
  • Lawson RA, Richardson SJ, Kershaw D, Davis D, Stephan B, Robinson L, Brayn C, Barnes L, Yarnall AJ, Taylor JP, Burn DJ, Parker S, Allan LM. Evaluation of Bedside Tests of Attention and Arousal Assessing Delirium in Parkinson’s Disease, Dementia, and Older Adults. Journal of Parkinson's Disease 2022, 12(2), 655-665.
  • Lawson RA, Williams-Gray CH, Camacho M, Duncan GW, Khoo TK, Breen DP, Barker RA, Rochester L, Burn DJ, Yarnall AJ. Which neuropsychological tests? Predicting cognitive decline and dementia in Parkinson’s disease in the ICICLE-PD cohort. Journal of Parkinson's Disease 2021, 11(3), 1297-1308.
  • Naisby J, Lawson RA, Galna B, Alcock L, Burn DJ, Rochester L, Yarnall AJ. Trajectories of pain over six years in early Parkinson’s disease: ICICLE-PD. Journal of Neurology 2021, 268, 4759-4767.
  • Colloby SJ, Nathan P, Bakker G, Lawson RA, Yarnall AJ, Burn DJ, OBrien JT, Taylor JP. Spatial covariance of cholinergic muscarinic M₁/M₄ receptors in Parkinson’s disease. Movement Disorders 2021, 36(8), 1879-1888.
  • Surendranathan A, Kane J, Bentley A, Barker S, McNally R, Bamford C, Taylor J-P, Thomas A, McKeith I, Burn D, O'Brien JT. Introduction of an assessment toolkit associated with increased rate of DLB diagnosis. Alzheimer's Research & Therapy 2021, 13, 50.
  • O'Brien JT, McKeith IG, Thomas AJ, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane JPM, Dunn S, Bentley A, Barker S, Mason J, Burn D, Taylor J-P. Introduction of a management toolkit for Lewy body dementia: A pilot cluster randomised trial. Movement Disorders 2021, 36(1), 143-151.
  • Tan MMX, Lawton MA, Jabbari E, Reynolds RH, Iwaki H, Blauwendraat C, Kanavou S, Pollard MI, Hubbard L, Malek N, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Bresner C, Foltynie T, Wood NW, Williams-Gray CH, Hardy J, Nalls MA, Singleton AB, Williams NM, Ben-Shlomo Y, Hu MTM, Grosset DG, Shoai M, Morris HR. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease. Movement Disorders 2021, 36(2), 424-433.
  • O'Brien JT, Taylor JP, Thomas A, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane J, Chrysos AE, Bentley A, Barker S, Mason J, Burn D, McKeith I. DTC-RP-PG-0311-12001: Improving the Diagnosis and Management of Neurodegenerative Dementia of Lewy Body Type in the NHS (DIAMOND-Lewy Programme). NIHR Journals Library 2021, 9(7).
  • Wilson J, Yarnall AJ, Craig CE, Galna B, Lord S, Morris R, Lawson RA, Alcock L, Duncan GW, Khoo TK, O'Brien JT, Burn DJ, Taylor JP, Ray NJ, Rochester L. Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease. Movement Disorders 2021, 36(3), 611-621.
  • Whiteside DJ, Jones PS, Ghosh BCP, Coyle-Gilchrist I, Gerhard A, Hu MT, Klein JC, Leigh PN, Church A, Burn DJ, Morris HR, Rowe JB, Rittman T. Altered network stability in progressive supranuclear palsy. Neurobiology of Aging 2021, 107, 109-117.
  • Hornsby AKE, Buntwal L, Carisi MC, Santos VV, Johnston F, Roberts LD, Sassi M, Mequinion M, Stark R, Reichenbach A, Lockie SH, Siervo M, Howell O, Morgan AH, Wells T, Andrews ZB, Burn DJ, Davies JS. Unacylated-Ghrelin Impairs Hippocampal Neurogenesis and Memory in Mice and Is Altered in Parkinson's Dementia in Humans. Cell Reports Medicine 2020, 1(7), 100120.
  • Bauermeister S, Orton C, Thompson S, Barker RA, Bauermeister JR, Ben-Shlomo Y, Brayne C, Burn D, Campbell A, Calvin C, Chandran S, Chaturvedi N, Chene G, Chessell IP, Corbett A, Davis DHJ, Denis M, Dufouil C, Elliott P, Fox N, Hill D, Hofer SM, Hu MT, Jindra C, Kee F, Kim C-H, Kim C, Kivimaki M, Koychev I, Lawson RA, Linden GJ, Lyons RA, Mackay C, Matthews PM, McGuiness B, Middleton L, Moody C, Moore K, Na DL, O'Brien JT, Ourselin S, Paranjothy S, Park K-S, Porteous DJ, Richards M, Ritchie CW, Rohrer JD, Rossor MN, Rowe JB, Scahill R, Schnier C, Schott JM, Seo SW, South M, Steptoe M, Tabrizi SJ, Tales A, Tillin T, Timpson NJ, Toga AW, Visser P-J, Wade-Martins R, Wilkinson T, Williams J, Wong A, Gallacher JEJ. The Dementias Platform UK (DPUK) Data Portal. European Journal of Epidemiology 2020, 35, 601-611.
  • Martin-Ruiz C, Williams-Gray CH, Yarnall AJ, Boucher JJ, Lawson RA, Wijeyekoon RS, Barker RA, Kolenda C, Parker C, Burn DJ, Von Zglinicki T, Saretzki G. Senescence and inflammatory markers for predicting clinical progression in Parkinson's disease-the ICICLE-PD study. Journal of Parkinson's Disease 2020, 10(1), 193-206.
  • Dlay JK, Duncan GW, Khoo TK, Williams-Gray CH, Breen DP, Barker RA, Burn DJ, Lawson RA, Yarnall AJ. Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD). Brain Sciences 2020, 10(2), 78.
  • Lawson RA, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM. Identifying delirium in Parkinson’s disease: a pilot study. International Journal of Geriatric Psychiatry 2020, 35(5), 547-552.
  • Wilson J, Alcock L, Yarnall AJ, Lord S, Lawson RA, Morris R, Taylor J-P, Burn DJ, Rochester L, Galna B. Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology. Frontiers in Aging Neuroscience 2020, 12, 577435.
  • Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR. Diagnosis across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology 2020, 77(3), 377-387.
  • McDonald C, Rees J, Winge K, Newton JL, Burn DJ. Bladder training for urinary tract symptoms in Parkinson disease. Neurology 2020, 94(13), e1427-e1433.
  • Gratwicke J, Zrinzo L, Kahan J, Peters A, Brechany U, McNichol A, Beigi M, Akram H, Hyam J, Oswal A, Day B, Mancini L, Thornton J, Yousry T, Crutch SJ, Taylor J-P, McKeith I, Rochester L, Schott JM, Limousin P, Burn D, Rossor MN, Hariz M, Jahanshahi M, Foltynie T. Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial. Brain Stimulation 2020, 13(4), 1031-1039.
  • Sleeman I, Lawson RA, Yarnall AJ, Duncan GW, Johnston F, Khoo TK, Burn DJ. Urate and homocysteine: predicting motor and cognitive changes in newly diagnosed Parkinson’s disease. Journal of Parkinson's Disease 2019, 9(2), 351-359.
  • Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Troster AI, Burn DJ, Litvan I, Geurtsen GJ. Risk of Parkinson's disease dementia related to level I MDS PD‐MCI. Movement Disorders 2019, 34(3), 430-435.
  • Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, Brooks DJ, Pavese N, Burn DJ. Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease. European Journal of Neurology 2019, 26(7), 979-985.
  • Malek N, Kanavou S, Lawton MA, Pitz V, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Williams NM, Wood N, Morris HR, Grosset DG. L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression. Parkinsonism and Related Disorders 2019, 65, 55-61.
  • King E, O'Brien J, Donaghy P, Williams-Gray CH, Lawson RA, Morris CM, Barnett N, Olsen K, Martin-Ruiz C, Burn DJ, Yarnall AJ, Taylor JP, Duncan GW, Khoo TK, Thomas A. Inflammation in Mild Cognitive Impairment due to Parkinson’s disease, Lewy Body disease and Alzheimer’s disease. International Journal of Geriatric Psychiatry 2019, 34(8), 1244-1250.
  • Tan MMX, Malek N, Lawton MA, Hubbard L, Pittman AM, Joseph T, Hehir J, Swallow DMA, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Bresner C, Foltynie T, Hardy J, Wood N, Ben-Shlomo Y, Grosset DG, Williams NM, Morris HR. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study. Brain: A journal of neurology 2019, 142(9), 2828-2844.
  • O'Dowd S, Schumacher J, Burn DJ, Bonanni L, Onofrj M, Thomas A, Taylor J-P. Fluctuating cognition in the Lewy body dementias. Brain : A Journal of Neurology 2019, 142(11), 3338-3350.
  • Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn DJ, Donaghy P, Morris CM, Taylor JP, Thomas AJ, Attems J, McKeith IG. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration 2019, 14, 5.
  • Lawson RA, McDonald C, Burn DJ. Defining delirium in idiopathic Parkinson’s disease: a systematic review. Parkinsonism and Related Disorders 2019, 64, 29-39.
  • Pasquini J, Durcan R, Wiblin L, Stokholm MG, Lynn Rochester L, Brooks DJ, Burn D, Pavese N. Clinical implications of early caudate dysfunction in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 2019, 90(10), 1098-1104.
  • Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J. Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study. International Journal of Geriatric Psychiatry 2018, 33(10), 1293-1304.
  • Gravell R, Duncan GW, Khoo TK, Burn DJ, Sayer AA, Barker RA, Lawson RA, Yarnall AJ. Multimorbidity predicts quality of life but not motor severity in early Parkinson's disease. Journal of Parkinson's Disease 2018, 8(4), 511-515.
  • Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD study. Journal of Neurology 2018, 265(7), 1528-1539.
  • Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, Morris HR. Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study. Journal of Neurology, Neurosurgery and Psychiatry 2018, 89(7), 702-709.
  • Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, Grosset DG, Hu MTM. Developing and validating Parkinson's disease subtypes and their motor and cognitive progression. Journal of Neurology, Neurosurgery and Psychiatry 2018, 89(12), 1279-1287.
  • Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu R-M, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Troster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests. Movement Disorders 2018, 33(11), 1750-1759.
  • Lawson RA, Collerton D, Taylor JP, Burn DJ, Brittain KR. Coping with cognitive impairment and Parkinson’s disease: perspectives from patients and carers. Parkinson's Disease 2018, 2018, 1362053.
  • Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub D. Cognition among individuals along a spectrum of increased risk for Parkinson’s disease. PLoS ONE 2018, 13(8), e0201964.
  • Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor J-P, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O'Brien JT. Clinical prevalence of Lewy body dementia. Alzheimer's Research & Therapy 2018, 10, 19.
  • Clegg BJ, Duncan GW, Khoo TK, Barker RA, Burn DJ, Yarnall AJ, Lawson RA. Categorising visual hallucinations in early Parkinson's disease. Journal of Parkinson's Disease 2018, 8(3), 447-453.
  • Marrinan SL, Otiker T, Vasist LS, Gibson RA, Sarai BK, Barton ME, Richards DB, Hellstrom PM, Nyholm D, Dukes GE, Burn DJ. A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease. Movement Disorders 2018, 33(2), 329-332.
  • Malek N, Lawton MA, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases. Parkinsonism and Related Disorders 2017, 40, 40-47.
  • Miller N, Nath U, Noble E, Burn D. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson’s disease, PSP and MSA-P. Neurodegenerative Disease Management 2017, 7(3).
  • Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, James B, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, Bloem BR, Van Der Eijk M, Rochester L, Williams A. Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease. npj Parkinson's Disease 2017, 3(1), 2.
  • Sleeman I, Aspray T, Lawson RA, Coleman S, Duncan GW, Khoo TK, Schoenmakers I, Barker R, Rochester R, Burn DJ, Yarnall AJ. The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease. Journal of Parkinson's Disease 2017, 7(4), 669-675.
  • Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Burn DJ. Stability of mild cognitive impairment in newly diagnosed Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 2017, 88, 648-652.
  • O'Dowd S, Galna B, Morris R, Lawson RA, McDonald C, Yarnall AJ, Burn DJ, Rochester L, Anderson KN. Poor Sleep Quality and Progression of Gait Impairment in an Incident Parkinson’s Disease Cohort. Journal of Parkinson's Disease 2017, 7(3), 465-470.
  • Lord S, Galna B, Yarnall AJ, Morris R, Coleman S, Burn D, Rochester L. Natural history of falls in an incident cohort of Parkinson’s disease: early evolution, risk and protective features. Journal of Neurology 2017, 264(11), 2268-2276.
  • Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu I-W, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang J-H, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, Hawkins KA, Litvan I, Richard I, Weintraub D, the Parkinson's Progression Markers Initiative (PPMI). Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. PLoS ONE 2017, 12(5), e0175674.
  • Hoogland J, Boel JA, de Bie RM, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Troster AI, Burn DJ, Litvan I, Geurtsen GJ. Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Movement Disorders 2017, 32(7), 1056-1065.
  • Burte F, Houghton D, Lowes H, Pyle A, Nesbitt S, Yarnall A, Yu-Wai-Man P, Burn DJ, Santibanez-Koref M, Hudson G. Metabolic profiling of Parkinson's disease and mild cognitive impairment. Movement Disorders 2017, 32(6), 927–932.
  • Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease. Neurobiology of Aging 2017, 55, 78-90.
  • Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, Kaiser M, Firbank MJ, O'Brien JT, Barker RA, Brooks DJ, Burn DJ, Taylor JP. Intra- and inter-network functional alterations in Parkinson's disease with mild cognitive impairment. Human Brain Mapping 2017, 38(3), 1702-1715.
  • Lord S, Galna B, Yarnall AJ, Coleman S, Burn D, Rochester L. Have we been overestimating fall rates in Parkinson's disease?. Movement Disorders 2017, 32(5), 803-804.
  • Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, Thompson WK, Hernandez DG, Djurovic S, Schork AJ, Bettella F, Ellinghaus D, Franke A, Lie BA, McEvoy LK, Karlsen TH, Lesage S, Morris HR, Brice A, Wood NW, Heutink P, Hardy J, Singleton AB, Dale AM, Gasser T, Andreassen OA, Sharma M, Nalls MA, Plagnol V, Sheerin U-M, Saad M, Simon-Sanchez J, Schulte C, Sveinbjornsdottir S, Arepalli S, Barker R, Ben-Shlomo Y, Berendse HW, Berg D, Bhatia K, De Bie RMA, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Bras JM, Brockmann K, Brooks J, Burn DJ, Majounie E, Charlesworth G, Lungu C, Chen H, Chinnery PF, Chong S, Clarke CE, Cookson MR, Cooper JM, Corvol JC, Counsell C, Damier P, Dartigues J-F, Deloukas P, Deuschl G, Dexter DT, Van Dijk KD, Dillman A, Durif F, Durr A, Edkins S, Evans JR, Foltynie T, Dong J, Gardner M, Goate A, Gray E, Guerreiro R, Harris C, Van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang X, Wurster I, Matzler W, Hudson G, Hunt SE, Huttenlocher J, Illig T, Jonsson PV, Lambert J-C, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, McNeill A, Moorby C, Moore M, Morrison KE, Escott-Price V, Mudanohwo E, O'Sullivan SS, Pearson J, Perlmutter JS, Petursson H, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Shulman J, Sidransky E, Smith C, Spencer CCA, Stefansson H, Stockton JD, Strange A, Talbot K, Tanner CM, Tashakkori-Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden AG, Velseboer D, Vidailhet M, Walker R, Van De Warrenburg B, Wickremaratchi M, Williams N, Williams-Gray CH, Winder-Rhodes S, Stefansson K, Martinez M, Ferrucci L, Johnson R, Longo DL, Nalls MA, O'Brien R, Troncoso J, Van Der Brug M, Zielke HR, Zonderman A, Hardy JA, Weale M. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. JAMA Neurology 2017, 74(7), 780-792.
  • Morris R, Lord S, Lawson RA, Coleman S, Galna B, Duncan GW, Khoo TK, Yarnall AJ, Burn DJ, Rochester L. Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease. Journal of Gerontology: Series A 2017, 72(12), 1656-1662.
  • Kobeleva X, Firbank M, Peraza L, Gallagher P, Thomas A, Burn DJ, O'Brien J, Taylor JP. Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer’s disease. Cortex 2017, 92, 8-18.
  • Jansen IE, Ye H, Heetveld S, Lechler MC, Michels H, Seinstra RI, Lubbe SJ, Drouet V, Lesage S, Majounie E, Gibbs JR, Nalls MA, Ryten M, Botia JA, Vandrovcova J, Simon-Sanchez J, Castillo-Lizardo M, Rizzu P, Blauwendraat C, Chouhan AK, Li Y, Yogi P, Amin N, van Duijn CM, Morris HR, Brice A, Singleton AB, David DC, Nollen EA, Jain S, Shulman JM, Heutink P, Hernandez DG, Arepalli S, Brooks J, Price R, Nicolas A, Chong S, Cookson MR, Dillman A, Moore M, Traynor BJ, Singleton, Plagnol V, Wood NW, Sheerin U-M, Bras JM, Charlesworth G, Gardner M, Guerreiro R, Trabzuni D, Hardy J, Sharma M, Saad M, Simon-Sanchez J, Schulte C, Corvol JC, Durr A, Vidailhet M, Sveinbjornsdottir S, Barker R, Williams-Gray CH, Ben-Shlomo Y, Berendse HW, van Dijk KD, Berg D, Brockmann K, Wurster I, Matzler W, Gasser T, Martinez M, de Bie RMA, Biffi A, Velseboer D, Bloem B, Post B, Wickremaratchi M, van de Warrenburg B, Bochdanovits Z, Bonin M, Petursson H, Riess O, Burn DJ, Lubbe S, Cooper JM, McNeill A, Schapira A, Lungu C, Chen H, Dong J, Chinnery PF, Hudson G, Clarke CE, Moorby C, Counsell C, Damier P, Dartigues J-F, Deloukas P, Gray E, Edkins S, Hunt SE, Potter S, Tashakkori-Ghanbaria A, Deuschl G, Lorenz D, Dexter DT, Durif F, Evans JR, Langford C, Foltynie T, Goate A, Harris C, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang X, Illig T, Jonsson PV, Lambert J-C, O'Sullivan SS, Revesz T, Shaw K, Lees A, Lichtner P, Limousin P, Lopez G, Escott-Price V, Pearson J, Williams N, Mudanohwo E, Perlmutter JS, Pollak P, Rivadeneira F, Uitterlinden AG, Sawcer S, Scheffer H, Shoulson I, Shulman J, Smith C, Walker R, Spencer CCA, Strange A, Stefansson H, Bettella F, Stefansson K, Stockton JD, Talbot K, Tanner CM, Tison F, Winder-Rhodes S, Bhatia K. Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing. Genome Biology 2017, 18, 22.
  • Thomas AJ, Taylor JP, Mckeith I, Bamford C, Burn D, Allan L, O'Brien J. Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: Feasibility study within the DIAMOND Lewy study. International Journal of Geriatric Psychiatry 2017, 32(12), 1280-1304.
  • Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G, Khoo TK, Mollenhauer B, Burn DJ. Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson’s disease. Neurology 2017, 88(16), 1501-1511.
  • Lawson RA, Yarnall AJ, Johnston F, Duncan GW, Khoo TK, Collerton D, Taylor JP, Burn DJ, on behalf of the ICICLE-PD study group. Cognitive impairment in Parkinson's disease: impact on quality of life carers. International Journal of Geriatric Psychiatry 2017, 32(12), 1362-1370.
  • Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, O'Brien JT, Barker RA, Maxwell RJ, Brooks DJ, Burn DJ. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson’s disease: ICICLE-PD study. Journal of Neurology, Neurosurgery, and Psychiatry 2017, 88(4), 310-316.
  • Thomas AJ, Attems J, Colloby SJ, O'Brien JT, Mckeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Autopsy validation of ¹²³ I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 2017, 88(3), 276-283.
  • Dissanayaka NNW, Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Barker RA, Burn DJ. Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson’s disease. Parkinsonism & Related Disorders 2017, 36, 63–68.
  • Urwyler P, Nef T, Müri R, Archibald N, Makin SM, Collerton D, Taylor JP, Burn D, McKeith I, Mosimann UP. Visual Hallucinations in Eye Disease and Lewy Body Disease. American Journal of Geriatric Psychiatry 2016, 24(5), 350-358.
  • Malek N, Lawton MA, Swallow DMA, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG, PRoBaND Clinical Consortium. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease. Movement Disorders 2016, 31(10), 1518-1526.
  • Hindle JV, Hurt CS, Burn DJ, Brown RG, Samuel M, Wilson KC, Clare L. The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson's disease-a longitudinal cohort study. International Journal of Geriatric Psychiatry 2016, 31(1), 13-23.
  • Swallow DMA, Lawton MA, Grosset KA, Malek N, Klein J, Baig F, Ruffmann C, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Hu MTM, Grosset DG, PRoBAND Clinical Consortium. Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts. Journal of Neurology, Neurosurgery and Psychiatry 2016, 87(11), 1183-1190.
  • Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, Cummings GA, Duncan GW, Khoo TK, Burn DJ, Barker RA, on behalf of the ICICLE-PD study group. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD). Movement Disorders 2016, 31(7), 995-1003.
  • Pyle A, Anugrha H, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G. Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease. Neurobiology of Aging 2016, 38, 216.e7–216.e10.
  • Lord S, Galna B, Yarnall AY, Coleman S, Burn D, Rochester L. Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort. Movement Disorders 2016, 31(12), 1829-1836.
  • Stamelou M, Schope J, Wagenpfeil S, Del Ser T, Bang J, Lobach IY, Luong P, Respondek G, Oertel WH, Boxer A, Hoglinger GU, Williams D, Lafontaine AL, Marras C, Jog M, Panisset M, Lang A, Parker L, Stewart AJ, Corvol J-C, Azulay J-P, Couratier P, Mollenhauer B, Lorenzl S, Ludolph A, Benecke R, Hoglinger G, Lipp A, Reichmann H, Woitalla D, Chan D, Zermansky A, Burn D, Lees A, Boxer A, Miller BL, Lobach IV, Roberson E, Honig L, Zamrini E, Pahwa R, Bordelon Y, Driver-Dunkley E, Lessig S, Lew M, Womack K, Boeve B, Ferrara J, Hillis A, Kaufer D, Kumar R, Xie T, Gunzler S, Zesiewicz T, Dayalu P, Golbe L, Grossman M, Jankovic J, McGinnis S, Santiago A, Tuite P, Isaacson S, Leegwater-Kim J, Litvan I, Grossman M, Knopman DS, Schneider LS, Doody RS, Golbe L, Koestler M, Jack CR, Van Deerlin V, Randolph C, Gozes I, Whitaker S, Hirman J, Gold M, Morimoto BH, Gomez JC, Tijero B, Berganzo K, Garcia de Yebenes J, Lopez Sendon JL, Garcia G, Tolosa E, Buongiorno MT, Bargallo N, Burguera JA, Martinez I, Ruiz-Martinez J, Narrativel I, Vivancos F, Ybot I, Aguilar M, Quilez P, Boada M, Lafuente A, Hernandez I, Lopez-Lozano JJ, Mata M, Kupsch A, Lipp A, Ebersbach G, Schmidt T, Hahn K, Hoglinger G, Hollerhage M, Reichmann H, Wolz M, Schneider C, Klingelhofer L, Berg D, Maetzler W, Srulijes KK, Ludolph A, Kassubek J, Steiger M, Tyler K, Burn DJ, Morris L, Lees A, Ling H, Hauser R, McClain T, Truong D, Jenkins S, Litvan I, Houghton D, Ferrara J, Bordelon Y, Gratiano A, Golbe L, Mark M, Uitti R, Ven Gerpen J, Bhatia K, Bordelon YM, Colosimo C, Dodel R, Josephs KA, Morris H, Mueller U, Paviour D, Schellenberg G, Steele J, van Swieten JC, Whitwell J. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. Movement Disorders 2016, 31(5), 742-747.
  • Malek N, Swallow DMA, Grosset KA, Lawton MA, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Bresner C, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Grosset DG, PRoBaND Investigators. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients. Acta Neurologica Scandinavica 2016, 134(4), 271-276.
  • Firbank M, Kobeleva X, Cherry G, Killen A, Gallagher P, Burn DJ, Thomas AJ, O'Brien JT, Taylor JP. Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease. Human Brain Mapping 2016, 37(3), 1254-1270.
  • Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ, Brooks DJ, Reddy AB, Rowe JB, Barker RA. Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease. Movement Disorders 2016, 31(7), 1062-1066.
  • Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?. Movement Disorders 2016, 31(1), 103-110.
  • Morris R, Lord S, Bunce J, Burn D, Rochester L. Gait and cognition: mapping the global and discrete relationships in ageing and neurodegenerative disease. Neuroscience & Biobehavioral Reviews 2016, 64, 326-345.
  • Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, Chinnery PF. Exome sequencing in dementia with Lewy bodies. Translational Psychiatry 2016, 6, e728.
  • Lawton M, Hu MTM, Baig F, Ruffmann C, Barron E, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, May MT, Grosset DG, Ben-Shlomo Y. Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease. Parkinsonism and Related Disorders 2016, 33, 96-101.
  • Wiblin L, Sleeman I, Burn D. Embarking on a research project…or research for the absolute novice. Journal of Royal College of Physicians in Edinburgh 2016, 46(3), 182-186.
  • Elder GJ, Colloby SJ, Lett DJ, O'Brien JT, Anderson KN, Burn DJ, McKeith IG, Taylor JP. Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2016, 31(7), 765-770.
  • Tang EYH, Burn D, Taylor JP, Robinson L. Dementia with Lewy Bodies: The Emerging Role of Primary Care. European Journal of General Practice 2016, 22(1), 53-57.
  • Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ. Cognitive decline and quality of life in incident Parkinson’s disease: the role of attention. Parkinsonism and Related Disorders 2016, 27, 47-53.
  • Martikainen MH, Ng YS, Gorman GS, Alston CL, Blakely EL, Schaefer AM, Chinnery PF, Burn DJ, Taylor RW, McFarland R, Turnbull DM. Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease. JAMA Neurology 2016, 73(6), 668-674.
  • Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O'Brien JT, Taylor JP. Cholinergic and perfusion brain networks in Parkinson disease dementia. Neurology 2016, 87(2), 178-185.
  • Yarnall AJ, Lashley T, Ling H, Lees AJ, Coleman SY, O'Sullivan SS, Compta Y, Revesz T, Burn DJ. Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?. Movement Disorders 2016, 31(5), 668-675.
  • Landau S, Harris V, Burn DJ, Hindle JV, Hurt CS, Samuel M, Wilson KC, Brown RG. Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis. Psychological Medicine 2016, 46(3), 657-667.
  • Sleeman I, Wiblin L, Burn D. An unusual cause of falls in a young woman. Journal of the Royal College of Physicians of Edinburgh 2016, 46(3), 160-162.
  • Carbutt S, Duff J, Yarnall A, Burn DJ, Hudson G. Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease. Neuroscience Letters 2015, 594, 66-69.
  • Malek N, Swallow DMA, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG, PRoBaND Clinical Consortium. Tracking Parkinson's: Study Design and Baseline Patient Data. Journal of Parkinson's Disease 2015, 5(4), 947-959.
  • Mactier K, Lord S, Godfrey A, Burn D, Rochester L. The relationship between real world ambulatory activity and falls in incident Parkinson's disease: Influence of classification scheme. Parkinsonism & Related Disorders 2015, 21(3), 236-242.
  • Guidi M, Paciaroni L, Paolini S, Scarpino O, Burn DJ. Semantic profiles in mild cognitive impairment associated with Alzheimer’s and Parkinson’s diseases. Functional Neurology 2015, 30(2), 113-118.
  • Pyle A, Brennan R, Kurzawa-Akanbi M, Yarnall A, Thouin A, Mollenhauer B, Burn D, Chinnery PF, Hudson G. Reduced CSF mitochondrial DNA is a biomarker for early-stage Parkinson's disease. Annals of Neurology 2015, 78(6), 1000-1004.
  • Galna B, Lord S, Burn DJ, Rochester L. Progression of Gait Dysfunction in Incident Parkinson's Disease: Impact of Medication and Phenotype. Movement Disorders 2015, 30(3), 359-367.
  • Stephenson D, Hu MT, Romero K, Breen K, Burn D, Ben-Shlomo Y, Bhattaram A, Isaac M, Venuto C, Kubota K, Little MA, Friend S, Lovestone S, Morris HR, Grosset D, Sutherland M, Gallacher J, Williams-Gray C, Bain LJ, Aviles E, Marek K, Toga AW, Stark Y, Gordon MF, Ford S. Precompetitive data sharing as a catalyst to address unmet needs in Parkinson's disease. Journal of Parkinson's Disease 2015, 5(3), 581-594.
  • Urwyler P, Nef T, Muri RM, Killen A, Collerton D, Burn D, McKeith I, Mosimann UP. Patient and Informant Views on Visual Hallucinations in Parkinson Disease. American Journal of Geriatric Psychiatry 2015, 23(9), 970-976.
  • Ballard C, Isaacson S, Mills R, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn DJ. Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. Journal of the American Medical Directors Association 2015, 16(10), 898.e1-898.e7.
  • Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA, Marek K, Jennings D, Tanner C, Kieburtz K, Poewe W, Mollenhauer B, Foroud T, Galasko D, Sherer T, Chowdhury S, Frasier M, Kopil C, Arnedo V, Rudolph A, Seibyl J, Mendick S, Schuff N, Caspell C, Uribe L, Foster E, Gloer K, Yankey J, Toga A, Berlin D, Casalin P, Malferrari G, Trojanowski J, Shaw L, Russell D, Factor S, Hogarth P, Standaert D, Hauser R, Jankovic J, Stern M, Chahine L, Frank S, Seppi K, Shill H, Berg D, Mari Z, Pavese N, Espay A, Devoto J, Rowe D, Brandabur M, Alcalay R, Tolosa E, York M, Leary L, Riordan C, Rees L, Portillo A, Lenahan A, Williams K, Guthrie S, Rawlins A, Harlan S, Hunter C, Tran B, Thomas C-A, James R, Sprenger F, Willeke D, Obradov S, Mule J, Gauss K, Fontaine D, Shah B, Ranola M, Sims JR. Cognitive Performance and Neuropsychiatric Symptoms in Early, Untreated Parkinson's Disease. Movement Disorders 2015, 30(7), 919-927.
  • Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain 2015, 138, 2974-2986.
  • Yarnall AJ, Lawson RA, Duncan GW, Breen DP, Khoo TK, Brooks D, Barker RA, Taylor JP, Burn DJ. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?. Journal of Parkinson's Disease 2015, 5(4), 743-743.
  • Martikainen MH, Gorman GS, Goldsmith P, Burn DJ, Turnbull DM, Schaefer AM. Adult-onset myoclonus ataxia associated with the mitochondrial m.8993T>C “NARP” mutation. Movement Disorders 2015, 30(10), 1432-1433.
  • Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DMA. Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathology and Applied Neurobiology 2015, 41(5), 601-612.
  • Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP. Visual complaints and visual hallucinations in Parkinson's disease. Parkinsonism & Related Disorders 2014, 20(3), 318-322.
  • Hurt CS, Burn DJ, Hindle J, Samuel M, Wilson K, Brown RG. Thinking positively about chronic illness: An exploration of optimism, illness perceptions and well-being in patients with Parkinson's disease. British Journal of Health Psychology 2014, 19(2), 363-379.
  • Rochester L, Galna B, Lord S, Burn D. The nature of dual-task interference during gait in incident Parkinson's disease. Neuroscience 2014, 265, 83-94.
  • Duncan GW, Khoo TK, Coleman SY, Brayne CE, Yarnall AJ, O'Brien JT, Barker RA, Burn DJ. The Incidence of Parkinson's Disease in the North East of England. Age and Ageing 2014, 43(2), 257-263.
  • Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ. The expanding universe of disorders of the basal ganglia. Lancet 2014, 384(9942), 523-531.
  • Cope TE, Grube M, Singh B, Burn DJ, Griffiths TD. The basal ganglia in perceptual timing: Timing performance in Multiple System Atrophy and Huntington's disease. Neuropsychologia 2014, 52, 73-81.
  • Godfrey A, Lord S, Galna B, Mathers J, Burn D, Rochester L. The association between retirement and age on physical activity in older adults. Age & Ageing 2014, 43(3), 386-393.
  • Cope TE, Grube M, Mandal A, Cooper FE, Brechany U, Burn DJ, Griffiths TD. Subthalamic deep brain stimulation in Parkinson's disease has no significant effect on perceptual timing in the hundreds of milliseconds range. Neuropsychologia 2014, 57, 29-37.
  • Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Cummins G, Galtrey C, Hellman B, Pal S, Stamford J, Steiger M, Williams A, The SMART-PD Investigators. Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): Study protocol for a randomised controlled trial (v7; 15 August 2014). Trials 2014, 15(1), 374.
  • Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life. Parkinsonism & Related Disorders 2014, 20(10), 1071-1075.
  • Kobylecki C, Burn DJ, Kass-Iliyya L, Kellett MW, Crossman AR, Silverdale MA. Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease. Parkinsonism & Related Disorders 2014, 20(4), 452-455.
  • Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ. Quality of Life and Mild Cognitive Impairment in Early Parkinson's Disease: Does Subtype Matter?. Journal of Parkinson's Disease 2014, 4(3), 331-336.
  • Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Burn DJ, Anderson KN. Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's Disease. Movement Disorders 2014, 29(2), 259-262.
  • Hurt CS, Alkufri F, Brown RG, Burn DJ, Hindle JV, Landau S, Wilson KC, Samuel M. Motor Phenotypes, Medication and Mood: Further Associations with Impulsive Behaviours in Parkinson's Disease. Journal of Parkinson's Disease 2014, 4(2), 245-254.
  • Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, Barker RA, Burn DJ. Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Movement Disorders 2014, 29(2), 195-202.
  • Nombela C, Rowe JB, Winder-Rhodes SE, Hampshire A, Owen AM, Breen DP, Duncan GW, Khoo TK, Yarnall AJ, Firbank MJ, Chinnery PF, Robbins TW, O'Brien JT, Brooks DJ, Burn DJ, Barker RA, ICICLE-PD Study Grp. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain 2014, 137, 2743-2758.
  • Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Hoglinger GU, Koestler M, Jack CR, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurology 2014, 13(7), 676-685.
  • Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, Takeda A, Weintraub D, Wenning GK, Movement Disorders Soc MSA MODIMSA. Cognitive Impairment in Multiple System Atrophy: A Position Statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) Study Group. Movement Disorders 2014, 29(7), 857-867.
  • Lord S, Galna B, Coleman S, Yarnall A, Burn D, Rochester L. Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease. Frontiers in Aging Neuroscience 2014, 6, 249.
  • Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ, ICICLE-PD Study Group. Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study. Neurology 2014, 82(4), 308-316.
  • Tolosa E, Litvan I, Hoglinger GU, Burn D, Lees A, Andres MV, Gomez-Carrillo B, Leon T, Del Ser T, Gomez JC, Tijero B, Berganzo K, Garcia de Yebenes J, Lopez Sendon JL, Garcia G, Tolosa E, Buongiorno MT, Bargallo N, Burguera JA, Martinez I, Ruiz-Martinez J, Narrativel I, Vivancos F, Ybot I, Aguilar M, Quilez P, Boada M, Lafuente A, Hernandez I, Lopez-Lozano JJ, Mata M, Kupsch A, Lipp A, Ebersbach G, Schmidt T, Hahn K, Hoglinger G, Hollerhage M, Oertel WH, Respondek G, Stamelou M, Reichmann H, Wolz M, Schneider C, Klingelhofer L, Berg D, Maetzler W, Srulijes KK, Ludolph A, Kassubek J, Steiger M, Tyler K, Burn DJ, Morris L, Lees A, Ling H, Hauser R, McClain T, Truong D, Jenkins S, Litvan I, Houghton D, Ferrara J, Bordelon Y, Gratiano A, Golbe L, Mark M, Uitti R, Ven Gerpen J. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Movement Disorders 2014, 29(4), 470-478.
  • Archibald NK, Hutton SB, Clarke MP, Mosimann UP, Burn DJ. Visual exploration in Parkinson's disease and Parkinson's disease dementia. Brain 2013, 136(3), 739-750.
  • Hudson G, Nalls M, Evans JR, Breen DP, Winder-Rhodes S, Morrision KE, Morris HR, Williams-Gray CH, Barker RA, Singleton AB, Hardy J, Wood NE, Burn DJ, Chinnery PF. Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology 2013, 80(22), 2042-2048.
  • Cope TE, Samaraweera APR, Burn DJ. Thyrotoxic Periodic Paralysis: Correct Hypokalemia with Caution. Journal of Emergency Medicine 2013, 45(3), 338-340.
  • Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, Barker RA, Burn DJ. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013, 80(3), 276-281.
  • Massey LA, Jaeger HR, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton J, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Micallef C. The midbrain to pons ratio A simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013, 80(20), 1856-1861.
  • Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW, Galna B, Burn DJ. Short latency afferent inhibition: A biomarker for mild cognitive impairment in Parkinson's disease?. Movement Disorders 2013, 28(9), 1285-1288.
  • Ford AH, Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Burn DJ, O'Brien JT. Rapid eye movement sleep behavior disorder in Parkinson's disease: Magnetic resonance imaging study. Movement Disorders 2013, 28(6), 832-836.
  • Lord S, Galna B, Coleman S, Burn D, Rochester L. Mild Depressive Symptoms Are Associated with Gait Impairment in Early Parkinson's Disease. Movement Disorders 2013, 28(5), 634-639.
  • Allen C, Counsell C, Farrin A, Al-Chalabi A, Dickie B, Leigh PN, Murphy CL, Payan C, Reynolds G, Shaw P, Steen IN, Thornhill M, Waters J, Zajicek J, Shaw PJ, Young CA, Morrison KE, Dhariwal S, Hornabrook R, Savage L, Burn DJ, Khoo TK, Kelly J, Dougherty A, Wijesekera L, Ellis CM, O'Hanlon K, Panicker J, Pate L, Ray P, Wyatt L, Young CA, Copeland L, Ealing J, Hamdalla H, Leroi I, Murphy C, O'Keeffe F, Oughton E, Partington L, Paterson P, Rog D, Sathish A, Sexton D, Smith J, Vanek H, Dodds S, Williams TL, Clarke J, Eziefula C, Howard R, Orrell R, Sidle K, Sylvester R, Barrett W, Merritt C, Talbot K, Turner MR, Talbot K, Williams C, Williams J, Cosby C, Hanemann CO, Imam I, Phillips C, Timings L, Crawford SE, Hewamadduma C, Hibberd R, Hollinger H, McDermott C, Mills G, Rafiq M, Taylor A, Waines E, Walsh T, Addison-Jones R, Birt J, Hare M, Majid T, UKMND-LiCALS Study Grp. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurology 2013, 12(4), 339-345.
  • Lord S, Galna B, Verghese J, Coleman S, Burn D, Rochester L. Independent Domains of Gait in Older Adults and Associated Motor and Nonmotor Attributes: Validation of a Factor Analysis Approach. Journals of Gerontology Series A: Biological Sciences & Medical Sciences 2013, 68(7), 820-827.
  • Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale. Movement Disorders 2013, 28(5), 668-670.
  • Lawson RA, Millar D, Brown RG, Burn DJ. Guided Self-Help for the Management of Worry in Parkinson's Disease: A Pilot Study. Journal of Parkinson's Disease 2013, 3(1), 61-68.
  • Gibson G, Mottram P, Burn D, Hindle J, Landau S, Samuel M, Hurt C, Brown R, Wilson K. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. International Journal of Geriatric Psychiatry 2013, 28(6), 626-631.
  • Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M. EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease. European Journal of Neurology 2013, 20(1), 16-34.
  • Lord S, Godfrey A, Galna B, Mhiripiri D, Burn D, Rochester L. Ambulatory activity in incident Parkinson's: more than meets the eye?. Journal of Neurology 2013, 260(12), 2964-2972.
  • Galna B, Lord S, Daud D, Archibald N, Burn D, Rochester L. Visual sampling during walking in people with Parkinson's disease and the influence of environment and dual-task. Brain Research 2012, 1473, 35-43.
  • Rochester L, Chastin SFM, Lord S, Baker K, Burn DJ. Understanding the impact of deep brain stimulation on ambulatory activity in advanced Parkinson's disease. Journal of Neurology 2012, 259(6), 1081-1086.
  • Charlesworth G, Gandhi S, Bras JM, Barker RA, Burn DJ, Chinnery PF, Gentleman SM, Guerreiro R, Hardy J, Holton JL, Lees A, Morrison K, Sheerin UM, Williams N, Morris H, Revesz T, Wood NW. Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiology of Aging 2012, 33(4), 838.e7.
  • Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MDW, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR. Systematic Review and UK-Based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. Movement Disorders 2012, 27(12), 1522-1529.
  • Burn DJ, Landau S, Hindle JV, Samuel M, Wilson KC, Hurt CS, Brown RG, PROMS-PD Study Grp. Parkinson's disease motor subtypes and mood. Movement Disorders 2012, 27(3), 379-386.
  • Winder-Rhodes SE, Garcia-Reitbock P, Ban M, Evans JR, Jacques TS, Kemppinen A, Foltynie T, Williams-Gray CH, Chinnery PF, Hudson G, Burn DJ, Allcock LM, Sawcer SJ, Barker RA, Spillantini MG. Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome. Movement Disorders 2012, 27(2), 312-315.
  • Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Frontotemporal Dementia in Elderly Individuals. Archives of Neurology 2012, 69(8), 1052-1060.
  • Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders 2012, 27(3), 349-356.
  • Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling HL, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jager HR. Conventional Magnetic Resonance Imaging in Confirmed Progressive Supranuclear Palsy and Multiple System Atrophy. Movement Disorders 2012, 27(14), 1755-1762.
  • Hurt CS, Landau S, Burn DJ, Hindle JV, Samuel M, Wilson K, Brown RG, PROMS-PD Study Grp. Cognition, coping, and outcome in Parkinson's disease. International Psychogeriatrics 2012, 24(10), 1656-1663.
  • Rochester L, Yarnall A, Baker MR, David R, Lord S, Galna B, Burn DJ. Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease. Brain 2012, 135(9), 2778-2787.
  • Yarnall AJ, Burn DJ. Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. Age and Ageing 2012, 41(5), 695-696.
  • Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Movement Disorders 2011, 26(13), 2387-2395.
  • Rochester L, Baker K, Nieuwboer A, Burn D. Targeting Dopa-Sensitive and Dopa-Resistant Gait Dysfunction in Parkinson's Disease: Selective Responses to Internal and External Cues. Movement Disorders 2011, 26(3), 430-435.
  • Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism & Related Disorders 2011, 17(6), 431-436.
  • Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A, Ferrari R, Moreno J, Momeni P, Duplessis D, Pal P, Rollinson S, Pickering-Brown S, Thompson JC, Neary D, Snowden JS, Perry R, Mann DMA. Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathologica 2011, 121(3), 365-371.
  • Hudson G, Faini D, Stutt A, Eccles M, Robinson L, Burn DJ, Chinnery PF. No evidence of substantia nigra telomere shortening in Parkinson's disease. Neurobiology of Aging 2011, 32(11), 2107.e3-2107.e5.
  • Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Arepalli S, Barker R, Ben-Shlomo Y, Berendse HW, Berg D, Bhatia K, de Bie RMA, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Bras JM, Brockmann K, Brooks J, Burn DJ, Charlesworth G, Chen HL, Chinnery PF, Chong S, Clarke CE, Cookson MR, Cooper JM, Corvol JC, Counsell C, Damier P, Dartigues JF, Deloukas P, Deuschl G, Dexter DT, van Dijk KD, Dillman A, Durif F, Durr A, Edkins S, Evans JR, Foltynie T, Gao JJ, Gardner M, Gibbs JR, Goate A, Gray E, Guerreiro R, Gustafsson O, Harris C, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang XM, Huber H, Hudson G, Hunt SE, Huttenlocher J, Illig T, Jonsson PV, Lambert JC, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, McNeill A, Moorby C, Moore M, Morris HR, Morrison KE, Mudanohwo E, O'Sullivan SS, Pearson J, Perlmutter JS, Petursson H, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Sidransky E, Smith C, Spencer CCA, Stefansson H, Stockton JD, Strange A, Talbot K, Tanner CM, Tashakkori-Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden AG, Velseboer D, Vidailhet M, Walker R, van de Warrenburg B, Wickremaratchi M, Williams N, Williams-Gray CH, Winder-Rhodes S, Stefansson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW, Int Parkinson Dis Genomics Consort, Wellcome Trust Case-Control Consor. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377(9766), 641-649.
  • Lord S, Baker K, Nieuwboer A, Burn D, Rochester L. Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction?. Journal of Neurology 2011, 258(4), 566-572.
  • Hurt CS, Thomas BA, Burn DJ, Hindle JV, Landau S, Samuel M, Wilson KCM, Brown RG. Coping in Parkinson's disease: an examination of the coping inventory for stressful situations. International Journal of Geriatric Psychiatry 2011, 26(10), 1030-1037.
  • Plagnol V, Nalls MA, Bras JM, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Amouyel P, Arepalli S, Band G, Barker RA, Bellinguez C, Ben-Shlomo Y, Berendse HW, Berg D, Bhatia K, de Bie RMA, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Brockmann K, Brooks J, Burn DJ, Charlesworth G, Chen HL, Chinnery PF, Chong S, Clarke CE, Cookson MR, Cooper JM, Corvol JC, Counsell C, Damier P, Dartigues JF, Deloukas P, Deuschl G, Dexter DT, van Dijk KD, Dillman A, Durif F, Durr A, Edkins S, Evans JR, Foltynie T, Freeman C, Gao JJ, Gardner M, Gibbs JR, Goate A, Gray E, Guerreiro R, Gustafsson O, Harris C, Hellenthal G, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang XM, Huber H, Hudson G, Hunt SE, Huttenlocher J, Illig T, Jonsson PV, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, McNeill A, Moorby C, Moore M, Morris H, Morrison KE, Mudanohwo E, O'Sullivan SS, Pearson J, Pearson R, Perlmutter JS, Petursson H, Pirinen M, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Sidransky E, de Silva R, Smith C, Spencer CCA, Stefansson H, Steinberg S, Stockton JD, Strange A, Su Z, Talbot K, Tanner CM, Tashakkori-Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden AG, Vandrovcova J, Velseboer D, Vidailhet M, Vukcevic D, Walker R, van de Warrenburg B, Weale ME, Wickremaratchi M, Williams N, Williams-Gray CH, Winder-Rhodes S, Stefansson K, Martinez M, Donnelly P, Singleton AB, Hardy J, Heutink P, Brice A, Gasser T, Wood NW, WTCCC2. A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease. PLoS Genetics 2011, 7(6), e1002142.
  • Gallagher P, Archibald N, Goldsmith P, Burn D. Two in the hand, an essential lesson in tremor management. Practical Neurology 2010, 10(3), 160-163.
  • Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen J, Barker R, Emre M. Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology 2010, 75(12), 1062-1069.
  • Hudson G, Schaefer AM, Taylor RW, Tiangyou W, Gibson A, Venables G, Griffiths P, Burn DJ, Turnbull DM, Chinnery PF. Mutation of the Linker Region of the Polymerase {gamma}-1 (POLG1) Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism. Archives of Neurology 2007, 64(4), 553-557.
  • Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, Burn DJ. Orthostatic hypotension in Parkinson's disease: Association with cognitive decline?. International Journal of Geriatric Psychiatry 2006, 21(8), 778-783.
  • Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor Subtype and Cognitive Decline in Lewy Body Disease: A Two-Year Longitudinal Study. Journal of Neurology, Neurosurgery and Psychiatry 2006, 77(5), 585-589.
  • McKeith IG, Rowan E, Askew K, Naidu A, Allan L, Barnett N, Lett D, Mosimann UP, Burn D, O'Brien JT. More severe functional impairment in dementia with Lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. American Journal of Geriatric Psychiatry 2006, 14(7), 582-588.
  • Miller N, Noble E, Jones D, Burn D. Life with communication changes in Parkinson's disease. Age and Ageing 2006, 35(3), 235-239.
  • Sun M, Latourelle JC, Wooten F, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF. Influence of heterozygosity for Parkin mutation on onset age in familial Parkinson disease The GenePD study. Archives of Neurology 2006, 63(6), 826-832.
  • Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu CC, Lane R. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders 2006, 21(11), 1899-1907.
  • Molloy SA, Rowan EN, O'Brien JT, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2006, 77(12), 1323-1328.
  • Allcock LM, Kenny RA, Burn DJ. Clinical phenotype of subjects with Parkinson's disease orthostatic hypotension: Autonomic symptom and demographic comparison. Movement Disorders 2006, 21(11), 1851-1855.
  • Mosimann UP, Rowan EN, Partington CE, Collerton D, Littlewood E, O'Brien JT, Burn DJ, McKeith IG. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. American Journal of Geriatric Psychiatry 2006, 14(2), 153-160.
  • Millar D, Griffiths P, Zermansky AJ, Burn DJ. Characterising behavioural and cognitive dysexecutive changes in progressive supranuclear palsy: use of the Katz Adjustment Scale-Relatives (KAS-R). Movement Disorders 2006, 21(2), 199-207.
  • Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76(9), 1200-1203.
  • Allan LM, Ballard CG, Burn DJ, Kenny RA. Prevalence and Severity of Gait Disorders in Alzheimer's and Non-Alzheimer's Dementias. Journal of the American Geriatrics Society 2005, 53(10), 1681-1687.
  • Nath U, Thomson R, Wood R, Ben-Shlomo Y, Lees A, Rooney C, Burn DJ. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Journal of Neurology, Neurosurgery and Psychiatry 2005, 76(4), 498-502.
  • Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ, Perry RH, Barker R, Burn DJ, Chinnery PF. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Annals of Neurology 2005, 57(4), 564-567.
  • Firbank MJ, Burn DJ, McKeith IG, O'Brien JT. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. International Journal of Geriatric Psychiatry 2005, 20(8), 776-782.
  • Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano L, Prakash R, Tobin S, Williamson J, Suchowersky O, Labell N, Growdon BNJ, Singer C, Watts R, Goldwurm S, Pezzoli G, Baker KB, Giroux ML, Pramstaller PP, Burn DJ, Chinnery P, Sherman S, Vieregge P, Litvan I, Gusella JF, Myers RH, Parsian A. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD study. Neurology 2005, 65(11), 1823-1825.
  • Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, Pakrasi S, Richardson J, Sanders J, McKeith IG. A comparison of the efficacy of donepezil in parkinson's disease with dementia and dementia with lewy bodies. International Journal of Geriatric Psychiatry 2005, 20(10), 938-944.
  • Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004, 63(11), 2091-2096.
  • Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, Ravina B, Eerola J, Perry RH, Jaros E, Tienari P, Weiser R, Gwinn-Hardy K, Morris CM, Hardy J, Singleton AB. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004, 63(3), 554-556.
  • Kleiner-Fisman G, Lang AE, Bergeron C, Burn DJ, Paviour DC. Rapidly progressive behavioral changes and Parkinsonism in a 68-year-old man. Movement Disorders 2004, 19(5), 534-543.
  • Burn DJ, Troster AI. Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 2004, 17(3), 172-180.
  • Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2004, 75(10), 1470-1471.
  • O'Brien JT, Colloby S, Fenwick J, Williams D, Firbank M, Burn DJ, McKeith IG. Dopamine transporter loss visualized with FP-CIT SPECT in dementia with Lewy bodies. Archives of Neurology 2004, 61(6), 919-925.
  • Stewart D, Morgan E, Burn D, Grosset D, Chaudhuri KR, MacMahon D, Needleman F, Macphee G, Heywood P. Dopamine agonist switching in Parkinson's disease. Hospital Medicine 2004, 65(4), 215-219.
  • Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IRA, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VMY, Trojanowski JQ. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004, 63(8), 1376-1384.
  • Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127(4), 791-800.
  • Appiah-Kubi L, Nisbet A, Burn DJ, Forbes A, Brechany U, Stegie F, Stutt A, Chaudhuri KR. Use and tolerability of cabergoline in young and older people with Parkinson’s disease: a multi center observational study. Journal of Applied Research 2003, 3(4), 356-362.
  • Collerton D, Burn D, McKeith I, O'Brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dementia and Geriatric Cognitive Disorders 2003, 16(4), 229-237.
  • Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith IG, Quinn NP, Sethi KD. SIC Task Force Appraisal of Clinical Diagnostic Criteria for Parkinsonian Disorders. Movement Disorders 2003, 18, 467-486.
  • Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. NeuroImage 2003, 20(2), 1309-1319.
  • Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Annals of Neurology 2003, 54(2), 235-238.
  • Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, Thomas A, Newby J, Reid J, O'Brien JT, McKeith IG. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Movement Disorders 2003, 18(8), 884-889.
  • McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. Dementia with Lewy bodies. Seminars in Clinical Neuropsychiatry 2003, 8(1), 46-57.
  • Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Movement Disorders 2003, 18(6), S72-S79.
  • Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study. Neurology 2003, 60(6), 910-916.
  • Cousins DA, Burton EJ, Burn D, Gholkar A, McKeith IG, O'Brien JT. Atrophy of the putamen in dementia Lewy bodies but not Alzheimer's disease - An MRI study. Neurology 2003, 61(9), 1191-1195.
  • Su Y, Allen CR, Geng D, Burn D, Brechany U, Bell GD, Rowland R. 3-D motion system ("data-gloves"): Application for Parkinson's disease. IEEE Transactions on Instrumentation and Measurement 2003, 52(3), 662-674.
  • Burn DJ, McKeith IG. Hallucinations in patients with parkinsonism: Clinical features and management. Geriatrics and Aging 2002, 5, 22-26.
  • Burn DJ. Depression in Parkinson’s disease. European Journal of Neurology 2002, 9(s3), 44-54.
  • Appiah-Kubi LS, Nisbet A, Burn DJ, Ray CK. Cabergoline monotherapy in clinical practice: A two year observational study of tolerability and efficacy in young, old and very elderly patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2002, 73(2), 231-231.
  • Burn DJ. Beyond the iron mask: towards better recognition and treatment of depression in Parkinson’s disease. Movement Disorders 2002, 17(3), 445-454.
  • Allen CR, Su Y, Geng, Burn D, Brechany U. 3D hand modelling and analysis using data-gloves: theory and its application in Parkinson’s disease. Acta Bioengineering Biomechanics 2002, 4(1), 3-30.
  • Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001, 124(7), 1438-1449.
  • Michell AW, Burn DJ. Isolated cerebellar syndrome following head injury with short posttraumatic amnesia. British Journal of Neurosurgery 2001, 15(6), 526-528.
  • Morris HR, Schrag A, Nath U, Burn D, Quinn NP, Daniel S, Wood NW, Lees AJ. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neuroscience Letters 2001, 312(2), 118-120.
  • Nath U, Burn DJ. The epidemiology of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Parkinsonism & Related Disorders 2000, 6(3), 145-153.
  • McKeith IG, Burn D. Spectrum of Parkinson's disease, Parkinson's dementia, and lewy body dementia. Neurologic Clinics 2000, 18(4), 865-883.
  • Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, Burn D, Ince P, Perry R, McKeith I. One year follow-up of parkinsonism in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 2000, 11(4), 219-222.
  • Thomas NJ, Morris CM, Scaravilli F, Johansson J, Rossor M, De Lange R, St Clair D, Nicoll J, Blank C, Coulthard A, Bushby K, Ince PG, Burn D, Kalaria RN. Hereditary vascular dementia linked to Notch 3 mutations: CADASIL in British families. Annals of the New York Academy of Sciences 2000, 903, 293-298.
  • Coulthard A, Blank SC, Bushby K, Kalaria RN, Burn DJ. Distribution of cranial MRI abnormalities in patients with symptomatic and subclinical CADASIL. British Journal of Radiology 2000, 73(867), 256-265.
  • Blank SC, Lyall R, Bushby KMD, Keers S, Coulthard A, Street E, Morris C, Kalaria RN, Ince P, Burn DJ. CADASIL in a British family: a multidisciplinary approach with NOTCH 3 mutation analysis. BRAIN, (In Press)<br>(Article) 2000.
  • Coulthard A, Hall K, English PT, Ince PG, Burn DJ, Bates D. Quantitative analysis of MRI signal intensity in new variant Creutzfeldt-Jakob disease. British Journal of Radiology 1999, 72(860), 742-748.
  • Goldsmith P, Burn DJ, Coulthard A, Jenkins A. Extrinsic cerebral venous sinus obstruction resulting in intracranial hypertension. Postgraduate Medical Journal 1999, 75(887), 550-551.
  • Ballard C, McKeith I, Burn D, Harrison R, OBrien J, Lowery K, Campbell M, Perry R, Ince P. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurologica Scandinavica 1997, 96(6), 366-371.
  • Marshall EF, Perry RH, Perry EK, Piggott MA, Thompson P, Jaros E, Burn DJ. Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration. Acta Neurologica Scandinavica 1997, 95(5), 287-292.
  • SPRIGGS DA, BURN DJ, FRENCH J, CARTLIDGE NEF, BATES D. IS BED REST USEFUL AFTER DIAGNOSTIC LUMBAR PUNCTURE. POSTGRADUATE MEDICAL JOURNAL 1992, 68(801), 581-583.

• Book Chapters

  • Burn DJ, Yarnall AJ. Motor symptoms and phenotype in patients with Parkinson’s disease dementia. In: Murat Emre, ed. Cognitive Impairment and Dementia in Parkinson's Disease. 2014.
  • Rochester L, Lord S, Yarnall AJ, Burn DJ. Falls in patients with dementia. In: Movement Disorders in Dementias. London: Springer, 2014, pp.45-60.
  • Burn DJ, Yarnall AJ. Dementia in Parkinson’s Disease. In: Chaudhuti, K.R., Tolosa, E., Schapira, A., Poewe, W, ed. Non-Motor Symptoms of Parkinson's Disease. Oxford, UK: Oxford University Press, 2013.
  • Burn DJ, Perry EK, O'Brien JT, et al. Dementia with Lewy Bodies. In: Charney, D.S., Nestler, E.J, ed. Neurobiology of Mental Illness. Oxford, UK: Oxford University Press, 2004, pp.881-895.
  • Burn DJ. Common errors and service deficiencies in the investigation and management of Parkinson’s disease. In: Findley, L., Hurwitz, B., Miles, A, ed. The Effective Management of Parkinson’s Disease. London, UK: Aesculapius Medical Press, 2004, pp.219-228.
  • Burn DJ, Mosimann UP, McKeith IG. Clinical Diagnosis of Dementia with Lewy Bodies. In: Litvan, I, ed. Atypical Parkinsonian Disorders: Clinical and Research Aspects. Totowa, NJ: Humana Press Inc, 2004, pp.361-373.
  • Burn DJ. Parkinson’s disease. In: Walker, R., Edwards, C, ed. Clinical Pharmacy and Therapeutics. Edinburgh, UK: Churchill Livingstone, 2003, pp.483-494.
  • Perry EK, Piggott MA, Johnson M, Ballard CG, McKeith IG, Burn DJ. Neurotransmitter correlates of neuropsychiatric symptoms in dementia with Lewy bodies. In: Bédard, M.-A, ed. Mental & Behavioural Dysfunction in Movement Disorders. Totowa, New Jersey, USA: Humana Press Inc, 2002, pp.285-294.
  • Perry EK, Burn DJ, McKeith IG, O'Brien J, Perry R. Lewy body diseases. In: Davis, K.L., Charney, D., Coyle, J.T., Nemeroff, C, ed. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott Williams & Wilkins, 2002, pp.1301-1316.
  • Kalaria RN, Cookson NJ, Mizuno T, Oakley A, Singleton AB, Morris CM, Coulthard A, Blank SC, Bushby KMD, Nicoll J, De Lange RPJ, Burn DJ, St Clair D. Microvascular pathology in familial multi-infarct dementia or CADASIL: implications for cerebral blood flow. In: Fukuuchi, Y; Tomita, M; Koto, A, ed. Ischemic Blood Flow in the Brain. Tokyo, New York: Springer, 2000, pp.431-442.

• Conference Proceedings (inc. Abstracts)

  • Stuart S, Alcock L, Nell J, Lawson RA, Morris R, Yarnall AJ, Burn D, Rochester L. Pro-saccades predict decline in attention over 18 months in newly diagnosed Parkinson’s disease. In: 21st International Congress of Parkinson's Disease and Movement Disorders. 2017, Vancouver, BC, Canada: John Wiley & Sons, Inc.
  • McDonald C, Lawson RA, Duncan GW, O'Dowd ST, Khoo TK, Yarnall AJ, Burn DJ. The Frequency and Progression of Genitourinary and Gastrointestinal Symptoms in Parkinson’s disease and Healthy Controls Over 36 months Follow-up in the ICICLE-PD Study. In: Parkinson’s UK Research Conference. 2016, Leeds.
  • Peraza LR, Lawson RA, Firbank JM, Yarnall A, Duncan GW, Khoo TK, Brooks D, O'Brien JT, Barker RA, Burn D, Taylor JP. Principal component discriminant analysis of mild cognitive impairment in Parkinson’s disease reveals early functional changes in the resting state. In: Neuroinformatics 2016 INCF Conference. 2016, Reading, UK: Frontiers Media S.A.
  • Martin-Bastida A, Schwarz S, Xing Y, Pietracupa S, Burn D, Silverdale M, Bajaj N, Grosset D, Auer D, Paola P. Neuromelanin-sensitive Resonance Imaging As a Parkinson's disease biomarker. In: ABN (Association of British Neurologists) Annual Meeting 2016. 2016, Brighton: BMJ Group.
  • Swallow DMA, Malek N, Grosset KA, Lawton MA, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Morris HR, Williams N, Wood NW, Grosset DG, PRoBaND Collaborators. Effects of vascular comorbidity in Parkinson's disease. In: Association of British Neurologists Annual Meeting. 2016, Brighton: BMJ Group.
  • Mak E, Su L, Williams G, Lawson R, Yarnall A, Gordon D, Adrian O, Tien K, Brooks D, Rowe J, Barker R, Burn D, O'Brien J. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. In: 17th IPA International. 2015, Berlin, Germany: Cambridge University Press.
  • Yarnall AJ, Del Din S, David R, Galna B, Baker MR, Burn DJ, Rochester L. Postural control stabilises over the first 30 seconds of quiet standing in Parkinson’s disease: time series analysis. In: International Parkinson and Movement Disorder Society's 18th International Congress of Parkinson's Disease and Movement Disorders. 2014, Stockholm, Sweden.
  • Barry G, Lord S, Godfrey A, Galna B, Burn D, Rochester L. Non-motor symptoms are associated with change in physical activity over 18 months in incident Parkinson’s disease (PD). In: 18th International Congress of Parkinson's Disease and Movement Disorders. 2014, Stockholm, Sweden: John Wiley & Sons, Inc.
  • Nesbitt D, Peraza LR, Lawson R, Yarnall A, Firbank M, Taylor J-P, Burn D. fMRI resting state connectivity in Parkinson's with mild cognitive impairment. In: Parkinson's UK Research Conference. 2014, York, UK.
  • Barry G, Lord S, Godfrey A, Galna B, Burn D, Rochester L. Drivers of change in physical activity over 18 months in incident Parkinson's disease. In: International Society of Posture and Gait Research World Congress. 2014, Vancouver, Canada.
  • Mactier KE, Lord S, Mhiripiri D, Burn D, Rochester L. Categorisation of falls in an incident cohort of Parkinson’s disease and effect of ambulatory activity on falls. In: The Eighteenth International Congress of Parkinson's Disease and Movement Disorders. 2014, Stockholm, Sweden: John Wiley & Sons, Inc.
  • Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Barker RA, Burn DJ. The impact of motor and non-motor symptoms upon health-related quality of life in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation: Parkinson's Disease (ICICLE-PD) Study. In: British Geriatrics Society Spring Meeting. 2013, Belfast, Ireland: Oxford University Press.
  • Boucher JJ, Duncan GW, Yarnall AJ, Martin Ruiz C, Barker RA, O'Brien JT, Von Zglinicki T, Burn DJ. Telomere length and cognitive impairment in early Parkinson's disease. In: 49th Annual Meeting of the Irish Neurological Association. 2013, Dublin: Irish Neurological Association.
  • Prudon B, Duncan GW, Yarnall AJ, Burn DJ, Anderson K. Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease. In: American Thoracic Society International Conference. 2013, Philadelphia: American Thoracic Society.
  • Duncan GW, Firbank MJ, Yarnall AJ, Barker RA, O'Brien JT, Burn DJ. Grey Matter Correlations of Cognitive Impairment in Early Parkinson's Disease: The Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation-Parkinson's Disease (ICICLE-PD) Study. In: Association of British Neurologists (ABN) Joint Meeting with the Royal College of Physicians (RCP). 2013, London, UK: BMJ Group.
  • Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, O'Brien JT, Barker RA, Burn DJ. Grey Matter Correlations of Cognitive Impairment in Early Parkinson's Disease: The Incidence of Cognitive Impairment In Cohorts with Longitudinal Evaluation: Parkinson's Disease (ICICLE-PD) Study. In: Age and Ageing. 2013, Oxford: Oxford University Press.
  • Duncan GW, Firbank MJ, Yarnall AJ, Barker RA, O'Brien JT, Burn DJ. Grey matter correlations of cognitive impairment in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation - Parkinson's disease (ICICLE-PD) study. In: British Geriatrics Society Spring Meeting. 2013, Belfast: British Geriatrics Society.
  • Duncan GW, Firbank MJ, Yarnall AJ, Barker RA, Burn DJ. Grey matter correlations of cognitive impairment in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation - Parkinson's disease (ICICLE-PD) study. In: Association of British Neurologists Annual Meeting 2013. 2013, Glasgow: Association of British Neurologists.
  • Duncan GW, Yarnall AJ, Firbank MJ, Barker RA, O'Brien JT, Burn DJ. Grey matter and CSF amyloid in early non-demented Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation - Parkinson's disease (ICICLE-PD) study. In: Association of British Neurologists Annual Meeting 2013. 2013, Glasgow, UK: Association of British Neurologists.
  • Khoo TK, Duncan GW, Yarnall AJ, Brooks DJ, Barker RA, O'Brien JT, Burn DJ. The incidence of Parkinson’s disease in North East England. In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Cope TE, Grube M, Singh B, Burn DJ, Griffiths TD. The Basal Ganglia in perceptual timing: Timing performance in multiple system atrophy and Huntington's Disease. In: Annual General Meeting of the British Neuropsychiatry Association. 2012, London: BMJ Group.
  • Nombela C, Rowe J, Hampshire A, Owen A, Breen D, Khoo T, Firbank M, Yarnall A, Duncan G, O'Brien J, Burn D, Brooks D, Barker R. Spatial planning ability in early stage Parkinson’s disease patients (ICICLE-PD). In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Lord S, Galna B, Godfrey A, Burn D, Rochester L. Patterns of daily ambulatory activity differ in early Parkinson's disease compared with controls. In: 16th International Congress of Parkinson's Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Nombela C, Rowe J, Hampshire A, Owen A, Breen D, Winder-Rhodes S, Khoo T, Firbank M, Yarnall A, Duncan G, O'Brien J, Burn D, Brooks D, Barker R. Inefficiency of fronto-parietal networks in incident Parkinson’s disease. In: 8th Forum of Neuroscience. 2012, Barcelona, Spain.
  • Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Brooks DJ, Barker RA, Burn DJ. Elevated homocysteine levels and cognitive dysfunction in an incident cohort of non-demented Parkinson’s disease patients. In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Khoo TK, Duncan GW, Yarnall AJ, Brooks DJ, Barker RA, O'Brien JT, Burn DJ. Depression and anxiety in incident Parkinson’s disease. In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Yarnall AJ, Rochester L, David R, Duncan GW, Khoo TK, Barker RA, Brooks DJ, Baker MR, Burn DJ. Cholinergic dysfunction in Parkinson’s disease with mild cognitive impairment: a short latency afferent inhibition study. In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Khoo TK, Duncan GW, Yarnall AJ, Brooks DJ, Barker RA, O'Brien JT, Burn DJ. Apathy in incident Parkinson’s disease. In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Yarnall AJ, Khoo TK, Duncan GW, Barker RA, Brooks DJ, Burn DJ. Anti-cholinergic load: Is there a cognitive cost in early Parkinson’s disease?. In: The Movement Disorders Society 16th International Congress of Parkinson’s Disease and Movement Disorders. 2012, Dublin, Ireland.
  • Godfrey A, Lord S, Dadirayi M, Burn D, Rochester L. Ambulatory activity but not sedentary behaviour discriminates early Parkinson's disease and controls. In: Joint World Congress of ISPGR and Gait & Mental Function. 2012, Trondheim, Norway.
  • Lord S, Baker K, Nieuwboer A, Burn D, Rochester L. Gait variability in Parkinson’s disease: Impact of dopamine and attention. In: 14th International Congress of Parkinson's Disease and Movement Disorders. 2010, Buenos Aires, Argentina: Movement Disorders: John Wiley & Sons, Inc.
  • Lord S, Rochester L, Hetherington V, Allcock L, Burn D. The role of cognitive and motor characteristics during single, dual and multi-task gait performance in Parkinson’s disease (PD). In: Parkinsonism & Related Disorders: 2nd International Congress on Gait & Mental Function. 2008, Amsterdam, Netherlands: Elsevier Ltd.
  • Burn DJ. Role of magnetic resonance spectroscopy in assessing neurodegenerative disease progression. In: Movement Disorders: 4th International Medical Workshop of the Progressive Supranuclear Palsy Association. 2004, Buckinghamshire, UK: John Wiley & Sons, Inc.
  • Chaudhuri KR, Taurah LS, MacMahon DG, Turner K, Kelly L, Burn D, Forbes A, Bowron A, Foster OJ, UK PD LIFE committee. PD LIFE - A prospective multi-centre longitudinal audit of Quality of Life in Parkinson's disease across the UK. In: Journal of Neurology, Neurosurgery and Psychiatry: Autumn Meeting of the Association of British Neurologists. 2004, Glasgow, UK: BMJ Group.
  • O'Brien JT, Colloby S, Pakrasi S, Burn D, Williams D, Wyper D, Owens J, McKeith I. I-123-QNB SPECT demonstrates loss of cholinergic muscarinic receptors in Alzheimer's disease, but occipital increases in dementia with lewy bodies and Parkinson's disease dementia. In: Neurobiology of Aging: 9th International Conference on Alzheimers Disease and Related Disorders. 2004, Philadelphia, Pennsylvania, USA: Elsevier Inc.
  • O'Brien JT, Colloby S, Burn D, Williams D. Dopamine transporter loss visualised with FP-CIT spect indementia with Lewy bodies. In: Neurobiology of Aging: 9th International Conference on Alzheimers Disease and Related Disorders. 2004, Philadelphia, Pennsylvania, USA: Elsevier Inc.
  • Molloy S, O'Brien JT, McKeith IG, Burn DJ. Can parkinsonian phenotype be used to predict levodopa response in extrapyramidal syndromes with and without dementia?. In: Journal of Neurology, Neurosurgery and Psychiatry: Spring Meeting of the Association of British Neurologists. 2004, London, UK: BMJ Group.
  • Warren NM, Piggott MA, Greally E, Lake M, Kilford L, Lees AJ, Burn DJ. Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy. In: Journal of Neurology, Neurosurgery and Psychiatry: Spring Meeting of the Association of British Neurologists. 2004, London, UK: BMJ Group.
  • Burn DJ, O'Brien JT. Use of functional imaging in parkinsonism and dementia. In: Workshop on Parkinsonism and Dementia. 2003, Istanbul, Turkey: Movement Disorders, John Wiley & Sons.
  • Chaudhuri KR, Taurah LS, MacMahon DG, Findley L, Kelly L, Burn D, Foster OJ, UKPDLIFE Comm. PDLIFE: A prospective multicentre longitudinal audit of quality of life in Parkinson's disease across the UK. In: Journal of Neurology, Neurosurgery and Psychiatry: Meeting of the Association of British Neurologists. 2003, Cardiff, UK: BMJ Group.
  • Nath U, Ben-Shlomo Y, Thomson RG, Wood N, Lees AI, Burn DJ. Clinical features and disease course of PSP in the United Kingdom. In: Journal of Neurology, Neurosurgery and Psychiatry: Association of British Neurologists Autumn Meeting. 2002, Durham: BMJ Group.
  • Su Y, Geng D, Allen CR, Burn D, Bell GD, Rowland R. Three-dimensional motion system ("data-gloves"): application for Parkinson's disease and essential tremor. In: IEEE International Workshop on Virtual and Intelligent Measurement Systems. 2001, Budapest, Hungary: IEEE.
  • Nath U, Morris H, Thomson R, Ben-Shlomo Y, Wood N, Lees A, Burn DJ. The prevalence of progressive supranuclear palsy in the United Kingdom. In: Journal of Neurology, Neurosurgery and Psychiatry. 2001, BMJ Group.
  • Allcock LM, Dey AB, Gibb I, Ball S, Burn D, Kenny RA. Neurohumoral and cardiovascular responses in Parkinson's disease with orthostatic hypotension. In: Journal of the American Geriatrics Society. 1999, Wiley-Blackwell Publishing, Inc.

• Editorials

  • Burn DJ. The treatment of mild cognitive impairment associated with Parkinson's disease. Movement Disorders 2015, 30(7), 881-882.
  • Burn DJ, Anderson K. To sleep, perchance to dement: RBD and cognitive decline in Parkinson's disease. Movement Disorders 2012, 27(6), 671-673.
  • Burn DJ. Cognitive testing in the diagnosis of Parkinsonian disorders: A lawn mower for the hare's corner?. Movement Disorders 2012, 27(10), 1201-1202.
  • Burn DJ. Editor's Introduction to Hot Topics in Movement Disorders: Literature Highlights. Movement Disorders 2011, 26(1), 4-4.
  • Burn DJ. Cortical Lewy body disease. Journal of Neurology, Neurosurgery and Psychiatry 2004, 75(2), 175-178.
  • Michell AW, Burn DJ, Reading PJ. Central pontine myelinolysis temporally related to hypophosphataemia. Journal of Neurology, Neurosurgery and Psychiatry 2003, 74(6), 820-820.
  • Burn DJ. The effects of deep brain stimulation and levodopa on postural sway in subjects with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2002, 73(3), 240.

• Letters

  • Lowes H, Robertson F, Pyle A, Hussain R, Coxhead J, Yarnall AJ, Burn D, Payne BAI, Santibanez-Koref M, Hudson G. The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease. Movement Disorders 2020, 35(12), 2134-2136.
  • Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Author response: Autopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 2017, 89(7), 751-751.
  • Martikainen MH, Burn DJ, Turnbull DM. Spectrum of Movement Disorders in Mitochondrial Disorders Reply. JAMA Neurology 2016, 73(10), 1254-1255.
  • Yarnall AJ, Ho BSW, Eshun E, David R, Rochester L, Burn DJ, Baker MR. Short latency afferent inhibition: Effects of ageing. Clinical Neurophysiology 2016, 127(6), 2410-2413.
  • Pyle A, Lowes H, Brennan R, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G. Reduced Mitochondrial DNA Is Not a Biomarker of Depression in Parkinson's Disease. Movement Disorders 2016, 31(12), 1923-1924.
  • Lovestone S, Rossor M, Gallacher J, Ritchie C, Burn D, Hyslop PS, Mackay C, Matthews PM, Ballard C, Georges J. Better together for better dementia research and care. The Lancet Psychiatry 2016, 3(6), 503-504.
  • Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R. Elderly Individuals With FTLD [Reply]. JAMA Neurology 2013, 70(3), 412-413.
  • Yarnall AJ, Duncan GW, Khoo TK, Burn DJ. Falling short: Underestimation of fracture risk in atypical parkinsonian syndromes. Parkinsonism and Related Disorders 2012, 18(5), 692-693.
  • Morris HR, Vaughan JR, Datta SR, Bandopadhyay R, de Silva HAR, Schrag A, Cairns NJ, Burn D, Nath U, Lantos PL, Daniel S, Lees AJ, Quinn NP, Wood NW. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology 2000, 55(12), 1918-1920.
  • Chinnery PF, Cartlidge N, Burn DJ, Cleland PG, McKeith I. Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria. Journal of Neurology, Neurosurgery and Psychiatry 1997, 62(5), 542-542.

• Notes

  • Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang H-L, Alcalay RN, Trenkwalder C. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders. Movement Disorders 2020, 35(5), 711-715.
  • Lakshminarayana R, Wang D, Burn D, Ray Chaudhuri K, Galtrey C, Valle Guzman N, Hellman B, James B, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, Bloem BR, van der Eijk M, Rochester L, Williams A. Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease. npj Parkinson's Disease 2017, 3(1), 32.

• Reviews

  • Taylor J-P, McKeith IG, Burn D, Boeve B, Weintraub D, Bamford C, Allan L, Thomas AJ, O'Brien JT. New evidence on the management of Lewy body dementia. The Lancet Neurology 2020, 19(2), 157-169.
  • Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders 2017, 32(9), 1264-1310.
  • Wiblin L, Lee M, Burn D. Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy. Parkinsonism and Related Disorders 2017, 34, 7–14.
  • McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management. Parkinsonism & Related Disorders 2017, 35, 8-16.
  • McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017, 89(1), 88-100.
  • Swallow DMA, Lawton MA, Grosset KA, Malek N, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams N, Wood NW, Grosset DG. Variation in recent onset Parkinson's disease: Implications for prodromal detection. Journal of Parkinson's Disease 2016, 6(2), 289-300.
  • McDonald C, Newton JL, Burn DJ. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?. Movement Disorders 2016, 31(7), 937-946.
  • Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Troster AI, Burn DJ, Litvan I, on behalf of the MDS Study Group on the validation PD-MCI criteria. Parkinson's Disease Mild Cognitive Impairment: Application and Validation of the Criteria. Journal of Parkinson's Disease 2014, 4(2), 131-137.
  • Marrinan S, Emmanuel AV, Burn DJ. Delayed Gastric Emptying in Parkinson's Disease. Movement Disorders 2014, 29(1), 23-32.
  • Duncan GW, Yarnall AJ, Marrinan S, Burn DJ. New horizons in the pathogenesis, assessment and management of movement disorders. Age and Ageing 2013, 42(1), 2-10.
  • Yarnall AJ, Rochester L, Burn DJ. Mild cognitive impairment in Parkinson's disease. Age and Ageing 2013, 42(5), 567-576.
  • Duncan GW, Firbank MJ, O'Brien JT, Burn DJ. Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?. Movement Disorders 2013, 28(4), 425-438.
  • Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T. Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease. Movement Disorders 2012, 27(5), 617-626.
  • Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson's disease. Movement Disorders 2011, 26(14), 2496-2503.
  • Weintraub D, Burn DJ. Parkinson's Disease: The Quintessential Neuropsychiatric Disorder. Movement Disorders 2011, 26(6), 1022-1031.
  • Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain 2005, 128(2), 239-249.
  • McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos MacHado J, O'Brien J, Playfer J, Reid W, On behalf of the International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurology 2004, 3(1), 19-28.
  • Burn DJ, Lee AJ. Progressive supranuclear palsy: where are we now?. Lancet Neurology 2002, 1(6), 359-369.
  • Burn DJ. Depression in Parkinson's disease. European Journal of Neurology 2002, 9(s3), 44-54.
  • Burn DJ. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Movement Disorders 2002, 17(3), 445-454.
  • Bhatia K, Brooks DJ, Burn DJ, Clarke CE, Grosset DG, MacMahon DG, Playfer J, Schapira AHV, Stewart D, Widliams AC, Parkinsons Dis Consensus Working G. Updated guidelines for the management of Parkinson's disease. Hospital Medicine 2001, 62(8), 456-470.
  • Burn DJ, Jaros E. Multiple system atrophy: cellular and molecular pathology. Molecular Pathology 2001, 54(6), 419-426.
  • Jaros E, Burn DJ. The pathogenesis of multiple system atrophy: Past, present, and future. Movement Disorders 2000, 15(5), 784-788.
  • Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999, 122(8), 1449-1468.